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Abstract
Background: Laboratory diagnosis of Chlamydophila psittaci, an important turkey respiratory
pathogen, is difficult. To facilitate the diagnosis, a nested PCR-enzyme immunoassay (PCR-EIA) was
developed to detect the Cp. psittaci outer membrane protein A (ompA) gene in pharyngeal swabs.
Methods: The fluorescein-biotin labelled PCR products were immobilized on streptavidin-coated
microtiter plates and detected with anti-fluorescein peroxidase conjugate and a colorimetric
substrate. An internal inhibition control was included to rule out the presence of inhibitors of DNA
amplification. The diagnostic value of the ompA nested PCR-EIA in comparison to cell culture and
a 16S-rRNA based nested PCR was assessed in pharyngeal turkey swabs from 10 different farms
experiencing respiratory disease.
Results: The sensitivity of the nested PCR-EIA was established at 0.1 infection forming units (IFU).
Specificity was 100%. The ompA nested PCR-EIA was more sensitive than the 16S-rRNA based
nested PCR and isolation, revealing 105 out of 200 (52.5%) positives against 13 and 74 for the latter
two tests, respectively. Twenty-nine (23.8%) out of 122 ompA PCR-EIA negatives showed the
presence of inhibitors of DNA amplification, although 27 of them became positive after diluting (1/
10) the specimens in PCR buffer or after phenol-chloroform extraction and subsequent ethanol
precipitation.
Conclusion: The present study stresses the need for an internal control to confirm PCR true-
negatives and demonstrates the high prevalence of chlamydiosis in Belgian turkeys and its potential
zoonotic risk. The ompA nested PCR-EIA described here is a rapid, highly sensitive and specific
diagnostic assay and will help to facilitate the diagnosis of Cp. psittaci infections in both poultry and
man.
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Avian chlamydiosis is caused by the obligate intracellular
Gram-negative bacterium Chlamydophila psittaci (formerly
Chlamydia psittaci). Currently, seven genotypes of Cp. psit-
taci are known to infect birds [1-3]. Avian chlamydiosis in
birds is usually systemic and occasionally fatal. The clini-
cal signs vary greatly in severity and depend on the spe-
cies, age of the bird and the strain of Cp. psittaci. Avian
chlamydiosis can produce lethargy, hyperthermia, abnor-
mal excretions, nasal and eye discharges, and reduced egg
production. Mortality rates range up to 30% [4]. Avian
chlamydiosis occurs worldwide, with the incidence and
distribution varying greatly with the species of bird and
the serotype of the chlamydial organism. In the past,
chlamydiosis in turkeys was thought to be limited to the
United States and to free-ranging flocks. Most outbreaks
in US turkeys were explosive, involving one or more flocks
[5-10]. Nowadays, the increase in confinement-rearing of
turkeys and the prevention of wild birds flying in and out
the turkey houses seems to contribute to a decrease of
severe outbreaks. Probably, the situation is comparable to
the one in Europe where, at present, Cp. psittaci is nearly
endemic in Belgian, German and probably French turkeys
[11-13]. However, devastating, explosive outbreaks with
high mortality rates occur occasionally, whereas present
outbreaks are mostly characterized by respiratory signs
without mortality [4]. Nevertheless, Cp. psittaci causes
important economical losses as a primary pathogen and
trough it's pathogenic interaction with other respiratory
pathogens like the avian pneumovirus (APV) and Ornitho-
bacterium rhinotracheale (ORT) [13]. Cp. psittaci is also a
threat to public health as this zoonotic agent can infect
humans and precautions should be taken when handling
infected birds or contaminated materials [14-17]. Human
infections are common following handling or processing
of infected turkeys or ducks [2,7,8,18]. Most infections are
through inhalation of infectious aerosols and subse-
quently processing plant employees, farm workers, veteri-
narians and poultry inspectors are at risk. However,
personnel who were employed to further process turkey
meat could also become infected [19].
Thus, diagnosis is essential. In contrast to cell culture and
serology, antigen detection methods like micro-immun-
ofluorescence and PCR provide a more rapid, specific and
sensitive alternative for identification of Cp. psittaci infec-
tion. However, currently described PCR assays for birds
use either labour intensive and/or insensitive post PCR
detection methods. A PCR-enzyme immunoassay (PCR-
EIA) would circumvent this problem. At the moment, we
are not aware of a nested PCR- enzyme immunoassay
(PCR-EIA) for demonstrating Cp. psittaci infection,
although the method has been successfully used for C.
pneumoniae detection in human respiratory specimens
[20,21].
The objective of the present study was to develop and
evaluate a rapid and simple EIA for semi-quantitative
detection of the amplified Cp. psittaci outer membrane
protein A (ompA) gene, included with an internal inhibi-
tion control to eliminate possible false positive results
during field sample analysis.
Methods
Specimens
In the fall of 2001, 200 fattening turkeys from 10 different
farms in Belgium (8 farms) or in Northern France (2
farms) were examined at slaughter for the presence of Cp.
psittaci. All turkeys had been vaccinated against Newcastle
disease (NCD) (Nobilis® ND LaSota; Intervet Interna-
tional, Boxmeer, The Netherlands) and in 7 out of 10
farms turkeys had also been vaccinated against APV
(Nobilis® RTV; Intervet International). Farmers provided
information about clinical symptoms throughout the
rearing period. All farms had experienced one or more
periods of respiratory disease.
Pharyngeal swabs were collected from 20 ad randomly
selected turkeys on each turkey farm. Of each turkey there
was taken 1 sample by using cotton tipped aluminium
shafted swabs (Fiers, Kuurne, Belgium) in Cp. psittaci
transport medium [22] consisting of: 0.2 M sucrose (VWR
International, Haasrode, Belgium); 0.015 M Na2HPO4
(VWR International), 0.01 M NaH2PO4 (VWR Interna-
tional) and 20% inactivated foetal calf serum (Integro,
Leuvenheim, The Netherlands). Swabs were shaken vigor-
ously for 1 hour and centrifuged (10 min, 2790 × g, 4°C).
One millilitre of supernatant was provided with 1% strep-
tomycin sulphate (10 mg/ml; Invitrogen), 2% vancomy-
cin (5 mg/ml; Glaxo Smith Kline) and 1.6% fungizone
(250µl/ml; Invitrogen) and subsequently used for Cp. psit-
taci isolation.
Generation of the internal control
The internal inhibition control was constructed starting
from the pcDNA1 vector in which the ompA gene of a Cp.
psittaci serovar D strain 92/1293 was inserted (Fig 1 &2)
[23]. First, a fragment of 231 bp of the ompA gene was
amplified using primers ML-BbrpI-F01 and ML-Bbrp1-
R01 (table 1), which provided a BbrpI restriction site at
their 5' end for subsequent cloning. The PCR reaction was
performed using Pfu DNA polymerase in 50 µl reactions
containing dNTP's (0.2 µM final concentration), Pfu
buffer (10x), ML-BbrpI-F01 and ML-Bbrp1-R01 (0.5 µM
final concentration), DMSO (7.5 %), Pfu DNA Polymer-
ase (2.5 U, Stratagene, La Jolla, USA) and 2 µg plasmid
DNA. After an initial denaturation at 95°C for 1 minute,
30 cycles of 30 seconds at 95°C, 30 seconds at 58°C and
1 minute at 72°C, followed by a final elongation at 72°C
for 10 min, were performed. PCR products were subjected
to electrophoresis on a 1.2% agarose gel stained withPage 2 of 9
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tion. Size was determined using Smart Ladder (Eurogen-
tec, Seraing, Belgium). PCR products were purified using
the Qiaquick PCR Purification kit (Qiagen) and ligated
into the pPCR-script™ Amp SK (+) vector (Stratagene, La
Jolla, USA), as described by the manufacturer. Next, the
vector was transformed into Epicurian coli XL10-Gold
Kan ultracompetente cells (Stratagene) using heat shock.
Clones were selected on Luria-Bertoni (LB) medium con-
taining ampicilin (100 µg/ml) and grown in microtiter
plates for 2 hours. The presence of the insert was con-
firmed by PCR clone analysis. Therefore, 5 µl of each
clone was subjected to PCR in a 50 µl reaction mixture
containing 50 mM KCl, 20 mM Tris-HCl (pH 8.3), 2 mM
MgCl2, 0.1% Tween20, 200 µM each dNTP, 1.25 µM of
each inner ompA primer (table 1) and 0.1 U SuperTaq
polymerase (5 U/µl). After an initial denaturation at 95°C
for 5 minutes, 20 cycles of one min at 95°C, two minutes
at 55°C and three minutes at 72°C, with a final extension
at 72°C for 5 min, were performed. To ensure PCR accu-
racy, the construct was sequenced using the ABI PRISM
Bigdye™ Terminator Cycle Sequencing Ready Reaction Kit
(ABI, Foster City, USA), following the manufacturers'
manual. Sequencing samples were analyzed on the ABI
PRISM 377 DNA sequencer (Perking Elmer).
Positive clones were grown overnight in 4 ml LB medium
containing ampicilin (100 µg/ml) and subjected to the
Qiaprep Spin Miniprep kit (Qiagen) to obtain purified
plasmid. Using BbrpI, the 231 bp fragment was cut out of
the pPCR-script™ Amp SK (+) vector and ligated into the
dephosphorylated Bbrp1 site, situated within the ompA
gene of the pcDNA1::MOMP vector [23]. Thus, the Bbrp1
restriction site is located within the target sequence of the
inner primers and subsequently, nested PCR amplifica-
tion of the inhibition control resulted in a PCR product of
703 bp (fig. 1). E. coli strain MC1061/P3 was transfected
by electroporation (Gene Pulser, Bio-Rad). Again, selected
clones were subjected to PCR clone analysis to asses the
presence of the insert and its sequence was determined by
the dideoxy chain terminating method, as described
above.
Preparation of positive control DNA
Cp. psittaci strains genotype A to F strains were propagated
in cycloheximide-treated BGM cells, as described else-
where [24]. Bacteria were harvested at approximately 72
hours by disrupting the cells by subsequent freezing and
thawing, followed by sonication and differential centrifu-
gation (Urografin 76%). Purified elementary bodies were
pelleted, washed, resuspended in sucrose-phosphate-
glutamate buffer, and stored in aliquots at -70°C. For
determination of bacterial titres, BGM monolayers grown
on glass cover slips (Chlamydia Trac Bottles, International
Medical) were infected and stained by the IMAGEN™
direct immunofluorescence assay [24]. Inclusion forming
units (IFU) were determined by counting the numbers of
inclusions cultured in duplicate in Chlamydia Trac Bottles
using 10-fold serial dilutions of purified EBs. Cp. psittaci
titres were expressed as IFU per millilitre and IFU
quantitated in this manner were used as the positive-con-
trol DNA in PCR assays.
Generation of the internal control using primers ML-Bbrp1-F01 and ML-Bbrp1-R01igure 1
Generation of the internal control using primers ML-Bbrp1-
F01 and ML-Bbrp1-R01.
Location of the outer and inner primers in the ompA geneFigure 2
Location of the outer and inner primers in the ompA 
gene.Numbering according to ompA sequences in GenebankPage 3 of 9
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Clinical specimens included pharyngeal swabs from tur-
keys taken at slaughter. These specimens as well as posi-
tive control DNA were prepared for ompA nested PCR-EIA
by the STD DNA extraction method, performed as fol-
lowed: Cp. psittaci suspensions or turkey specimens were
pelleted at 13,000 x g, resuspended in 198 µl STD buffer
(0.01 M Tris-HCl [pH 8.3], 0.05 M KCl, 0.0025 M
MgCl2.6H20, 0.5% Tween20) and 2 µl proteinase K (20
mg/ml stock solution; Sigma Chemical Co.). The speci-
mens were incubated at 56°C for one hour and subse-
quently heated at 100°C for 10 min. Samples for both
PCR's were prepared in a class II laminar flow hood, and
amplification and analysis of PCR products were per-
formed in separate locations.
The nested ompA PCR-EIA was developed using external
and internal primers (table 1) generating a biotin-fluores-
cein dual labelled internal PCR product of 472 bp. Both
inner and outer sense primers are located within the first
conserved domain (CD1) of ompA, whereas the inner anti-
sense primer is located in CD3 and the outer anti-sense
primers overlaps CD4 and variable domain 4 (fig. 2). First
round PCR occurred in 50 mM KCl, 20 mM Tris-HCl (pH
8.3), 2 mM MgCl2, 0.1% Tween20, 200 µM each dNTP,
1.25 µM each external primer (table 1) and 0.1 U Super-
Taq polymerase (5 U/µl). After an initial denaturation at
95°C for 5 minutes, 20 cycles of one min at 95°C, two
min at 59°C and three min at 72°C, with a final extension
at 72°C for 5 min were performed. Second round ampli-
fication was performed under similar conditions, using
labelled internal primers (each 10 µM; table 1), adapted
annealing temperature (47°C) and adapted number of
cycles (25). Subsequently, nested PCR generated a fluores-
cein/biotin dual-labelled product of 472 bp. To minimize
false-positive results, each step of the nested PCR was per-
formed in physically separated places.
To allow colorimetric detection of the ompA PCR prod-
ucts, 50 µl of the PCR product diluted 1/10 in PBS supple-
mented with 3% BSA was transferred in duplicate to
streptavidin-coated microtiter plates (2 µg/well for 3
hours at 37°C) and incubated at 37°C for one hour. Non-
specific binding places were blocked overnight (4°C) with
5% BSA in PBS. Subsequently, the plates were washed
twice with PBS and incubated (1 hour, 37°C) with a
horseradish peroxidase labelled anti-fluorescein antibody
(Invitrogen), diluted 1/1000 in PBS supplemented with
3% BSA. Following incubating and washing with PBS, the
ABTS substrate solution (2,2' azino-di-3-ethylbenzothia-
zoline sulphonate, KPL) was added to the wells. Absorb-
encies were read at 450 nm after incubating for 30
minutes at 37°C (TiterTek MultiskanR Plus, MKII, Tech-
Gen Internatonal). Three positive controls consisting of
serial 10-fold dilutions of PCR products generated from 5
IFU of Cp. psittaci and five negative controls (water) were
included in each assay. Results were positive if the absorb-
ance exceeded the cut off value of the mean of negative
controls plus three times the standard deviation. Nested
PCR-EIA negative samples were re-tested after adding 10
ng internal inhibition control and visualized by gel elec-
trophoresis to assess possible inhibition.
The sensitivity of the PCR was evaluated by testing 10-fold
serial dilutions of DNA extracted from purified elemen-
tary bodies of Cp. psittaci strains 92/1293 [2]. Next, diag-
nosis of six reference strains of Cp. psittaci serovars A-F was
assessed (table 2). The specificity was determined by test-
ing DNA extracted from other bacterial species commonly
found in the avian respiratory tract and avian respiratory
tract tissue, originating from Cp. psittaci negative specific
pathogen free turkeys (CNEVA, Ploufragan, France). The
following micro-organisms were tested for cross-reactivity
in the PCR assay with both the first- and second-step PCR
primers: Acinetobacter species, Aspergillus flavus, Candida
albicans, Enterococcus faecelis, Escherichia coli, Klebsiella spe-
cies, Mycobacterium avium, Mycoplasma gallisepticum, Myco-
Table 1: Oligonucleotides used in this study
Oligonucleotide Length (bp) Sequence (5'-3')
Sense outer 16 rRNA 18 ACG GAA TAA TGA CTT CGG
Anti-sense outer 16S rRNA 18 TAC CTG GTA CGC TCA ATT
Sense inner 16S rRNA 21 ATA ATG ACT TCG GTT GTT ATT
Anti-sense inner 16S rRNA 20 TGT TTT AGA TGC CTA AAC AT
ML-BbrpI-F01 29 GCC ACG TGC GTC TGC AAC ACT CAA ATA TC
ML-BbrpI-R01 28 GGC ACG TGC AGT TGT AAG AAG TCA GAG T
Sense outer ompA 21 CCT GTA GGG AAC CCA GCT GAA
Anti-sense outer ompA 22 GGT TGA GCA ATG CGG ATA GTA T
Fluorescein-sense inner ompA 17 GCA GGA TAC TAC GGA GA
Biotin-antisense inner ompA 18 GGA ACT CAG CTC CTA AAGPage 4 of 9
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Pasteurella species, Proteus mirabilis, Pseudomonas species,
Salmonella enteritidis, Salmonella gallinarum, Salmonella pul-
lorum, Staphylococcus species, Streptococcus species and Xan-
thomonas maltophila. A Cp. psittaci positive control of 1 IFU
was included in every test to verify that the PCR was
working.
16S-rRNA nested PCR – gel electrophoresis
The performance of the ompA nested PCR-EIA was com-
pared to those of isolation and another nested PCR, tar-
geting the 16S rRNA gene [25]. Cp. psittaci suspensions or
turkey specimens were prepared for PCR by the QiaAmp
Blood kit (Qiagen Inc., Chatworth, Califormia) adapted
by [25]. Genus-specific first-step primers and species-spe-
cific second step primers generated PCR products of 436
bp and 127 bp, respectively (table 1). Amplification prod-
ucts were visualized by gel electrophoresis (1.5% Nusieve
GTG agarose, FMC Bioproducts, Rockland, Maine). PCR
negatives were spiked with 5 IFU of Cp. psittaci to control
for the presence of inhibitors. The limit of detection of
this 16S-rRNA-based PCR was 5 IFU as previously
described [25]. Samples for both PCR's were prepared in a
class II laminar flow hood, and amplification and analysis
of PCR products were each performed in separate
locations.
Comparison to Cp. psittaci isolation
Pharyngeal swabs were examined for the presence of via-
ble Cp. psittaci by isolation in cycloheximide-treated Buf-
falo Green Monkey (BGM) cells. Swabs were shaken at
4°C for 1 hour and centrifuged (10 minutes, 2790 × g,
4°C). The supernatant was used for Cp. psittaci isolation in
BGM cells and subsequent identification using the
IMAGEN™ direct immunofluorescence assay (DakoCyto-
mation, Denmark), as previously described [24]. All inoc-
ulated monolayers were stained at 6 days post
inoculation. Inclusion-negative cultures were passaged
once. After adding an equal volume of sucrose phosphate
glutamate (SPG; [25]) and freezing at -80°C, cultures
were thawed, cell suspensions were sonicated and centri-
fuged once (2000 x g). Supernatant was inoculated in
duplicate onto new BGM monolayers as described else-
where [24]. Staining was performed at 3, and if negative at
6 days post inoculation.
Validation
A specimen was considered positive if culture positive. In
addition, a culture-negative, but 16S rRNA-based PCR
positive specimen was considered to be a true positive
only if it could be verified by ompA-based PCR.
Results
Development of the nested PCR-EIA
Optimizing PCR conditions was performed using STD
extracted DNA of Cp. psittaci serovar D strain 92/1293. Ini-
tial PCR with temperature gradients were performed with
either inner or outer primer sets separately to determine
optimal annealing temperature for both primer sets. The
optimal annealing temperature for outer and inner primer
sets was determined at 59°C and 47°C, respectively (data
not shown). Next, optimal primer dilutions were tested to
obtain a single band as nested PCR product, after visuali-
zation on 1.2% agarose gel (fig. 3). Hereto, external prim-
ers were used at 0.625 µM and internal primers at 10 µM.
First and second round PCR amplification with the outer
and inner primers resulted in PCR products of 872 bp and
472 bp, respectively. After amplification biotinylated PCR
products were immobilized to streptavidin-coated micro-
titer wells and detected with anti-fluorescein peroxidase
conjugate and a colorimetric substrate. Next, optimal
enzyme immunoassay conditions were realised, among
others by diluting the dual labelled PCR product 1/10 in
dilution buffer (PBS + 3% BSA + 2% IgG free horse
serum). All incubation steps and reaction components of
this EIA were optimized prior to use with pharyngeal
swabs.
Sensitivity
Following definition of optimal reagent and reaction con-
ditions, sensitivity and specificity of the ompA nested PCR
was determined. The STD DNA-extraction was performed
on 108 IFU and tenfold dilutions of the purified DNA were
subjected to the nested PCR and visualised on a 1.2% aga-
Table 2: Cp. psittaci reference strains
Strain Year Country Host Serovar Reference
VS 1 1985 USA, Georgia Amazona sp. A [34]
CP3 1957 USA, Calofornia Columba livia B [35]
GD 1960 Germany Anas platyrhynchos C [36]
NJ1 1954 USA, New Jersey Meleagris gallopavo D [37]
MN 1934 USA, California Homo sapiensa E [38]
VS225 1991 USA, Texas Parakeet F [39]
a Probably originated from birds, isolated in ferrets from human [39].Page 5 of 9
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bp and a detection limit of 10-2 IFU (fig. 4A). Subjecting
the dual-labelled nested PCR product to the EIA, resulted
also in a detection limit of 10-2 IFU (fig. 4B) and there was
a linear relationship between the measured absorbance
and the tenfold dilution series. However, when the ten-
fold dilution series of Cp. psittaci elementary bodies was
made prior to the STD DNA-extraction, sensitivity
decreased one log to 10-1 IFU. Similarly, when field
samples, which tested negative by nested PCR, were
spiked with the serial tenfold dilutions, sensitivity
decreased to 10-1 IFU.
Amplification of chlamydial DNA and the internal inhibi-
tion control was achieved with the ompA inner and outer
primer sets, as the additional DNA fragment for the inhi-
bition control was inserted within the target sequence of
the ompA inner primer set. Therefore, the nested PCR
amplification of Cp. psittaci cultures or inhibitory sub-
stance-free clinical specimens, which were positive for Cp.
psittaci exhibited two bands on ethidium-stained agarose
gel electrophoresis: one band (472 bp) diagnostic for Cp.
psittaci and a control band (703 bp) for the internal inhi-
bition control (fig 3). Inhibitory substance-free clinical
specimens negative for Cp. psittaci contained only the con-
trol band, indicating that no detectable inhibitors were
present and that biochemical conditions were optimal for
PCR amplifications. When inhibitory substances were
present in field samples, no bands were detected on
ethidium-stained agarose gel. Adding 10 ng of inhibition
control to the nested PCR mixture was determined as the
optimal condition to assess inhibition in field samples
(fig 3).
Specificity
The nested PCR-EIA was able to detect al 6 tested Cp. psit-
taci reference strains (table 2), whereas strains of Chlamy-
dia trachomatis, Chlamydophila pneumoniae, Chlamydophila
abortus and Chlamydophila felis remained undetected. Fur-
thermore, avian respiratory tract tissue originating from
Cp. psittaci negative specific-pathogen-free turkeys
(CNEVA, Ploufragan, France) and a wide range of non-
chlamydial bacteria were tested and showed no cross-reac-
tivity with: Acinetobacter species, Aspergillus flavus, Candida
Different conditions observed in the nested PCR-EIA analysis of Cp. psittaci in turkey fi ld samplesFigu  3
Different conditions observed in the nested PCR-EIA 
analysis of Cp. psittaci in turkey field samples. Lane 1: 
molecular marker (BenchTop 1 kb DNA ladder; Promega); 
lane 2: Cp. psittaci positive sample, showing one band (472 
bp) diagnostic for Cp. psittaci and a band (703 bp) for the 
internal inhibition control; lane 3: Cp. psittaci negative sample, 
showing only the internal inhibition control band; lane 4: a 
sample with inhibitory substances lacking both the Cp. psit-
taci-specific band and the internal inhibition control band; 
lane 5: negative control, free from Cp. psittaci DNA and inter-
nal control DNA.
(A) Nested PCR-EIA analysis on a tenfold serial dilution of Cp. psittaci strain 92/1293Figur  4
(A) Nested PCR-EIA analysis on a tenfold serial dilu-
tion of Cp. psittaci strain 92/1293. (B) Visualisation of 
the tenfold serial dilution on a 1.2% agarose gel fol-
lowing nested PCR. 103 IFU (lane 1) until 10-2 IFU (lane 6). 
Lane 7 shows the PCR results on a negative control. Lane 8: 
Phage lambda PstI fragments as size marker.Page 6 of 9
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cies, Mycobacterium avium, Mycoplasma gallisepticum, Myco-
plasma meleagridis, Ornithobacterium rhinotracheale,
Pasteurella species, Proteus mirabilis, Pseudomonas species,
Salmonella enteritidis, Salmonella gallinarum, Salmonella
pullorum, Staphylococcus species, Streptococcus species and
Xanthomonas maltophila. A Cp. psittaci positive control of 1
IFU was included in every test to verify that the PCR was
working.
Analysis of pharyngeal specimens
Two hundred turkeys from 10 different farms in Belgium
(8 farms) or in Northern France (2 farms) were examined
at slaughter for the presence of Cp. psittaci. All farms had
experienced one or more periods of respiratory disease.
All samples have been analysed for the presence of Cp.
psittaci by isolation in BGM cells, nested PCR-EIA and 16S
rRNA nested PCR (table 3). The pharyngeal swabs were
inoculated onto cycloheximide-treated BGM cells. Cp.
psittaci was isolated from 54 specimens (27%) after the
first inoculation and from 20 additional samples (10%)
following one passage. Thus, 74 out of 200 (37%) speci-
mens revealed to be culture positive. They were all con-
firmed as culture positive by ompA nested PCR-EIA
analysis of the infected BGM monolayers. One hundred
and twenty six samples remained negative, notwithstand-
ing an additional 6 days passage on BGM cells. OmpA
nested PCR-EIA was able to detect chlamydial DNA suc-
cessfully in 105 on 200 (52.5%) pharyngeal swabs. How-
ever, 29 out of 122 (23.8%) PCR-EIA negatives clearly
demonstrated inhibition showing no internal control
band on the agarose gel. Seventeen out of 29 samples
containing inhibitors became positive after prior 1/10
dilution in PCR buffer. Specimens that still showed inhi-
bition were subjected to phenol-chloroform extraction
and ethanol precipitation to further purify the DNA and
were retested. Ten tested positive for Cp. psittaci, but 2 of
29 specimens continued to show inhibition. Thus, finally
105 out of 200 (52.5%) pharyngeal swabs tested positive
by the ompA nested PCR-EIA. Surprisingly, the 16S rRNA-
based PCR could only confirm 13 out of 105 ompA PCR
positives revealing a total of 6.5% positive turkeys. Nine
of these 13 positives could be confirmed by isolation
while the remaining 4 were negative by isolation but pos-
itive by ompA PCR, indicating that they were true
positives.
Referring to isolation as a reference, all 10 examined farms
were Cp. psittaci positive at slaughter. The same was true
when looking at the ompA nested PCR results. Although
apparently less sensitive, the 16S rRNA PCR detected Cp.
psittaci in 50% of the examined farms.
Discussion
A nested PCR-EIA based on the detection of the ompA gene
was developed and evaluated for the diagnosis of chlamy-
diosis in turkeys. Nested PCR resulted in a 5' fluorescein
and 3' biotin labelled ompA fragment of 472 bp which was
subsequently detected in an enzyme immunoassay.
Although the designed inner and outer anti-sense primers
showed few nucleotide mismatches as compared to the
ompA sequences of Cp. psittaci genotype C, D and F refer-
ence strains, amplification of Cp. psittaci genotypes A to F
strains consistently resulted in the anticipated nested
PCR-EIA product. The nested PCR-EIA was 100% specific
as all Cp. psittaci genotypes were detected, but no C. tracho-
matis, C. pneumoniae, C. abortus or C. felis DNA. Addition-
ally, no cross-reactivity was observed with other bacterial
respiratory pathogens commonly found in the avian res-
piratory tract or with turkey respiratory tract DNA.
Nested PCR was chosen in order to obtain high sensitivity
and specificity. Amplification of internal control DNA
helped us in confirming true-negative PCR results by rul-
ing out the presence of inhibitors of DNA amplification.
Adding 10 ng of the internal inhibition control did not
comprise sensitivity, as 10-2 IFU of all Cp. psittaci genotype
reference strains was detected. However, when field sam-
ples, which tested negative in the nested PCR-EIA were
spiked with the tenfold DNA dilutions, sensitivity
decreased to 10-1 IFU, probably due to the higher amount
of background DNA.
In the present study, 200 commercial turkeys, originating
from 10 different farms in Belgium (8 farms) or Northern
France (2 farms) were sampled at slaughter to examine for
the presence of Cp. psittaci. Isolation in BGM cells revealed
74 (37%) positives. Application of the ompA nested PCR-
Table 3: Results of nested PCR's on turkey pharyngeal specimens compared to isolation as a reference test
Isolation N OmpA PCR 16S rRNA PCR
positive negative positive negative
Negatives 126 31 95 4 122
Positives 74 74 0 9 65
Total 200 105 95 13 187Page 7 of 9
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results. Moreover, the ompA nested PCR-EIA detected 31
additional positives, resulting in a total of 105 (52.5%)
Cp. psittaci positive turkeys. However, 29 (23.8%) of the
105 PCR-EIA positives were initially negative by the EIA
and during retesting, when the internal control was added
to the PCR mix, they demonstrated inhibition lacking the
internal control band on an EtBr stained agarose gel. Yet,
17 samples became positive after prior 1/10 dilution of
the specimen in PCR buffer. Moreover, after phenol-chlo-
roform extraction and ethanol precipitation all but two of
the sample became positive. Those two samples could not
be diagnosed by the ompA nested PCR-EIA, as inhibitory
substances could not be removed. Culture and 16S rRNA
nested PCR for those 2 samples were also negative. How-
ever as the latter two tests have shown to be less sensitive
and consequently, the presence or absence of Cp. psittaci
in these 2 samples cannot be conclude. The present results
clearly demonstrate the importance of using an internal
control to help identify true-negatives when examining
turkey pharyngeal swabs, as inhibition of DNA amplifica-
tion seem to occur rather frequently in these specimens.
Notwithstanding the presence of polymerase inhibitors,
pharyngeal swabs still remain the first choice for sampling
live birds. Pharyngeal specimens are preferred as cloacal
shedding of Cp. psittaci is intermittent and, in contrast, the
respiratory tract appears to be the last system to be cleared
of infection. Furthermore, pathogenesis of Cp. psittaci
revealed that lateral nasal glands can be infected for a
extended period [26]. Secretions of these glands function
to keep the mucosa moist and drainage of infected
secretions into the pharyngeal cavity can serve as source
for Cp. psittaci. Also secretions from the lung are expelled
into the pharyngeal area [27].
Surprisingly, the 16S rRNA-based PCR could only confirm
13 out of 105 ompA nested PCR-EIA positives revealing
only 6.5% positive turkeys. Discrepant results were prob-
ably not due to different extraction methods, as 30 16S-
rRNA negative samples remained negative even after using
the STD extraction method as for the ompA - based nested
PCR.
The PCR-EIA turned out to be more sensitive than isola-
tion in cell culture and more sensitive than the 16S rRNA-
based nested PCR. The 16S-rRNA PCR primers have
already been shown to be sensitive (5 IFU) and specific
[25]. The ompA nested PCR-EIA is approximately 50 times
more sensitive than the 16S-rRNA based PCR. The sensi-
tivity of the nested PCR-EIA was also superior to isolation
of Cp. psittaci in cell culture, which is in agreement with
other reports [28-30]. Moreover, the nested PCR-EIA is
easy, rapid, and less labour-intensive than isolation and
non-viable Chlamydiaceae can be detected, due to the rela-
tive high stability of DNA. This allows less stringent
demands on collection, transportation and storage of the
samples, making the nested PCR-EIA an ideal diagnostic
method for monitoring turkey flocks during processing.
Referring to isolation as a reference, all 10 examined farms
were Cp. psittaci positive at slaughter. The same was true
when looking at the ompA nested PCR results. Although
apparently less sensitive, the 16S rRNA PCR still detected
Cp. psittaci in 50% of the examined farms. Results are in
concordance with previous reports, demonstrating the
high prevalence of Cp. psittaci in Belgian turkeys [13]. Pub-
lic health is here of concern, as poultry workers, veterinary
surgeons and slaughterhouse employees are at risk of
becoming infected by this zoonotic agent [9,15,16,19,31-
33]. In the present study, 37% of the turkeys were still
shedding infectious Cp. psittaci, when transported to the
slaughterhouse posing a threat to human health. Thus, the
presented ompA nested PCR-EIA will help to facilitate the
diagnosis of Cp. psittaci infections in both poultry and
man.
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